Related Experiment Video
Updated: Jun 23, 2025

07:41
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
8.9K
NNBGWO-BRCA marker: Neural Network and binary grey wolf optimization based Breast cancer biomarker discovery
Min Li1, Yuheng Cai1, Mingzhuang Zhang1
1School of Information Engineering, Nanchang Institute of Technology, No. 289 Tianxiang Road, Nanchang Jiangxi, PR China.
Computer Methods and Programs in Biomedicine
|June 23, 2024
Summary
This study introduces a novel deep learning framework to identify breast cancer biomarkers from multi-omics data. The approach successfully classified breast cancer subtypes with high accuracy, paving the way for targeted therapies.
Area of Science:
- Biomedical Informatics
- Computational Biology
- Genomics
Background:
- Breast cancer poses a significant mortality risk, necessitating early detection and precise classification.
- Multi-omics data integration is crucial for identifying breast cancer biomarkers and subtypes.
- Deep learning offers potential for analyzing complex multi-omics data but lacks robust feature selection methods.
Purpose of the Study:
- To propose a novel deep learning framework, NNBGWO-BRCAMarker, for discovering breast cancer biomarkers from multi-omics data.
- To leverage neural networks and grey wolf optimization for effective feature selection in biomarker discovery.
- To enable precise classification of breast cancer subtypes for targeted therapeutic strategies.
Main Methods:
- A two-phase framework: 1) Gene selection using feedforward neural network weights. 2) Further gene screening via binary grey wolf optimization.
- Utilized multi-omics data for comprehensive biomarker identification.
- Employed Support Vector Machine (SVM) with RBF kernel for classification accuracy assessment.
Main Results:
- Identified 80 potential breast cancer biomarkers using the NNBGWO-BRCAMarker framework.
- Achieved a classification accuracy of 0.9242 ± 0.03 for breast cancer subtypes using the identified biomarkers.
- Uncovered 25 druggable genes, 16 enriched pathways, and 8 prognostic genes through subsequent analyses.
Conclusions:
- The NNBGWO-BRCAMarker framework successfully identified key biomarkers for accurate breast cancer subtype classification.
- The discovered biomarkers and associated analyses provide valuable insights for clinical research and personalized medicine.
- This study highlights the potential of integrating deep learning with optimization algorithms for multi-omics-based biomarker discovery.

